Global Oncology Academy

Exploring the Role of Biomarkers in Lung Cancer Treatment 

ReachMD Healthcare Image

How can biomarkers help us select the best treatment option for our patients with lung cancer? 

  • Overview

    Treatment for lung cancer can be complex, but PL-L1 expression and tumor mutational burden might help us select the best treatment for our patients. What do we need to know about the role of these biomarkers in the treatment of lung cancer?  To discuss this, Dr. Jacob Sands is joined by Dr. Biagio Ricciuti, a medical oncologist at the Dana-Farber Cancer Institute.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free